LEXINGTON, Mass. & MUNICH--(BUSINESS WIRE)--RainDance Technologies, Inc., the Digital Biology™ Company, and the MLL Munich Leukemia Laboratory (MLL) today announced that MLL will be releasing data for a new myeloid hematological malignancies gene panel generated using RainDance Technologies’ ThunderStorm™ System coupled with Illumina’s MiSeq™ platform. MLL will present initial results from a technology evaluation and research study at the 54th Annual American Society of Hematology (ASH) meeting next week in Atlanta.
